Company intelligence / Profile preview

Centient Biotech Investor

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

The Centient Biotech Investor was a specialized investment advisory and newsletter service focused on the biotechnology and pharmaceutical industries during the mid-2000s. Published by San Diego-based Centient Consulting, Inc., the newsletter provided in-depth investment analysis, market commentary, and stock recommendations for institutional and individual biotech investors. The firm was notably recognized for maintaining the "Centient Biotech 200" index, a benchmark that tracked the performance of 200 publicly traded biotechnology companies. Led by co-founder and Chief Scientific Officer Frank Eeckman, the company also offered strategic consulting services to life science firms and was a frequent contributor to biotech news platforms like BioSpace.

Industry: Consulting

Beyond the preview

Go deeper on Centient Biotech Investor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Centient Biotech Investor.

Explore the full profile